Review: A review of the use of zonisamide in Parkinson’s disease
Although zonisamide was previously only used to treat epilepsy, recently more applications have been forthcoming. Due to a good side effect profile, a lower frequency of interactions and a more comfortable posology, there are several studies regarding its uses in other pathologies such as migraine,...
Main Authors: | Pedro Emilio Bermejo, Buenaventura Anciones |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-09-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756285609338501 |
Similar Items
-
Zonisamide for the Treatment of Parkinson Disease: A Current Update
by: Chengqian Li, et al.
Published: (2020-12-01) -
Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson’s Disease
by: Hiroshi Kataoka, et al.
Published: (2012-01-01) -
Zonisamide effects on sleep problems and depressive symptoms in Parkinson’s disease
by: Keisuke Suzuki, et al.
Published: (2021-03-01) -
Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
by: Shin-Ichi Ueno, et al.
Published: (2018-12-01) -
Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
by: Haruo Nishijima, et al.
Published: (2018-01-01)